Express Pharma - Express Pharma

India formulation sales for Q2 FY2023 were Rs 15,841 mn, up 6.2 per cent as compared to Rs 14,920 mn in Q1 FY2023

The brand unveiled 30 plus products under two verticals, Normalife and Normahealth

Doxycyline capsule is a generic equivalent of Galderma Laboratories' Oracea capsules

The company now expects annual revenue to be near the low end of its prior forecast range of between $2 billion and $2.3 billion

Product awaiting the US FDA approval, targetted at treating seizures in neonatal patients

Revenue from operation grew by 11 per cent to Rs 3,202 crore versus Rs 2,889 crore in H1FY22

Dr Rutter will lead NIH efforts to speed translation of scientific discoveries into new treatments and other health interventions

The company will display Macofar Oftalmica and STF 120 rigid tube filler

Prior to joining UNS, Pratin led the 2,000 crore India formulations business at Emcure Pharma

Their findings, based on research with fruit flies and mouse heart cells, were published in 'Communications Biology,' a 'Nature'…